Recombinant human bone morphogenetic protein-2 in debridement and impacted bone graft for the treatment of femoral head osteonecrosis.
The purpose of this study was to compare the clinical outcomes of impacted bone graft with or without recombinant human bone morphogenetic protein-2 (rhBMP-2) for osteonecrosis of the femoral head (ONFH). We examined the effect of bone-grafting through a window at the femoral head-neck junction, kno...
Main Authors: | Wei Sun, Zirong Li, Fuqiang Gao, Zhencai Shi, Qidong Zhang, Wanshou Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4067369?pdf=render |
Similar Items
-
Investigating Clinical Failure of Bone Grafting through a Window at the Femoral Head Neck Junction Surgery for the Treatment of Osteonecrosis of the Femoral Head.
by: Wei Zuo, et al.
Published: (2016-01-01) -
Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head
by: Huachen Yu, et al.
Published: (2020-04-01) -
Femoral Osteonecrosis after Medial Femoral Condyle Bone Graft Harvest
by: Jorge G. Boretto, MD, et al.
Published: (2018-06-01) -
Bone tissue engineering for treating osteonecrosis of the femoral head
by: Yixin Bian, et al.
Published: (2023-04-01) -
A minimally invasive technique of core decompression and cancellous bone grafting of femoral head osteonecrosis
by: P.B. Rajeev, et al.
Published: (2024-12-01)